Data Sheet Specifications:
Description
Monoclonal antibody of 100 µl targeting GP2 for FCM, ICC, IHC.
| Target: | GP2 |
|---|---|
| Product Type: | Antibody |
| Size: | 100 µL |
| Application: | FCM, ICC, IHC |
| Research Area / Disease: | Immunology |
| Conjugate: | Unlabeled |
| Antibody Type: | Monoclonal |
| Clone Number: | 3G7-H9 |
| Concentration: | 1 mg/mL |
| Formulation: | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained. |
| Isotype: | IgG1 ĸ |
| Immunogen: | Human Fc fusion protein of human GP2 quality except the transmembrane region |
| Host Species: | Mouse |
| Species Reactivity: | Human |
| Source: | This antibody was purified from mouse ascites fluid using protein G agarose. This hybridoma (clone 3G7-H9) was established by fusion of mouse myeloma cell P3U1 with Balb/c mouse lymphocyte immunized with recombinant human GP2-human IgG Fc fusion protein d |
| Reactivity: | This antibody reacts with human GP2 on Immunohistochemistry, Immunocytochemistry and Flow cytometry. |
| Storage Temperature: | -20°C |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
Citations
- Hase K et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 462, 226-230 (2009),
- Kujala P et al. Prion uptake in the gut: identification of the first uptake and replication sites. PLoS Pathg. 7, e1002449 (2011),
- Kunisawa J et al. Gut-associated lymphoid tissues for the development of oral vaccines. Adv Drug Deliv Rev. 64, 523-30 (2012)
References
- Hase, K., et al., Nature 462, 226-230 (2009)
- Terahara, K., et al., J. Immunol. 180, 7840-7846 (2008)